To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement

NCT05116215 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: Hydrogen

Sponsor

HoHo Biotech

Collaborators

[object Object]